Biocompounds Pharmaceutical Inc. was founded in 2003. It is a high-tech enterprise integrating R&D, manufacturing, and sales, with a focus on pharmaceutical APIs, intermediates, and agrochemical TC. Biocompounds has been recognized as a national-level “Little Giant” enterprise for specialized and sophisticated SMEs, and has established an expert workstation and a Small Molecule Targeted Drug Research Institute. It has also been successively accredited as a Shanghai High-tech Enterprise, a Songjiang District Enterprise Technology Center, and a Songjiang District G60 Class I Key Supported Enterprise.
2003
335
400
Mu20
+Biocompounds Pharmaceutical Inc. continuously drives technological innovation and has built a lean manufacturing platform, offering customers high-quality, cost-competitive pharmaceutical APIs, intermediates, and agrochemical TC.
APIs
Pharmaceutical Intermediates
Agrochemical TC
After years of development, Biocompounds has established an excellent team for pharmaceutical process research and quality research, boasting a pharmaceutical research and development laboratory building and a quality control center. The company has undertaken multiple research and development innovation projects, been awarded as a Songjiang District Enterprise Technology Center, and obtained ISO9001/14001/18001 quality management system certifications, striving to build a standardized research and development platform for chemical pharmaceuticals.
Anhui Biocompounds Chemicals Co., Ltd Located within the Dongzhi Economic Development Zone in Chizhou, Anhui Province, it covers an area of 290 acres and is a wholly-owned subsidiary of Biocompounds Pharmaceutical Inc.
Anhui Bocompounds Pharmaceutical Co., Ltd Located within the Dongzhi Economic Development Zone in Chizhou, Anhui Province, it covers an area of 118 acres and is a wholly-owned subsidiary of Biocompounds Pharmaceutical Inc.
After years of development, Biocompounds has established an excellent team for pharmaceutical process research and quality research, boasting a pharmaceutical research and development laboratory building and a quality control center. The company has undertaken multiple research and development innovation projects, been awarded as a Songjiang District Enterprise Technology Center, and obtained ISO9001/14001/18001 quality management system certifications, striving to build a standardized research and development platform for chemical pharmaceuticals.
In terms of product mix, Biocompounds focuses on small molecule active pharmaceutical ingredients (APIs) and advanced intermediates, implementing upstream and downstream collaboration and tackling key product areas, covering antibacterial and influenza drugs, central nervous system drugs, cardiovascular drugs, gastrointestinal drugs, and anti-tumor drugs.
In implementing our strategy, we revisit each synthetic route from first principles, eliminating redundant steps to maximize material utilization and reaction efficiency. Through meticulous management, we reduce costs and enhance efficiency across the entire process, from material selection and reaction optimization to waste treatment.
2026.05
On May 19 and 21, Biocompounds Pharmaceutical Inc. successively received drug re
2026.05
Recently, the Anhui Provincial Drug Administration issued an announcement statin
2026.03
Recently, Anhui Bocompounds Pharmaceutical Co., Ltd successfully obtained the ex
Shanghai
Address：Building D4, No. 3802, Shengang Road, Songjiang District, Shanghai
Postcode：201611
Telephone：+86-021-57687675
Email：info@biocompounds.com
Anhui Site
Address：Dongzhi Economic Development Zone, Chizhou City, Anhui Province, China
Postcode：247260
Scan to follow us on WeChat
Copyright © 2026 - Biocompounds Pharmaceutical Inc. All Rights Reserved |
沪ICP备16031718号-1
沪(松)应急管危经许[2020]204726(QY)
